Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Peijia Medical Ltd. ( (HK:9996) ) is now available.
Peijia Medical Ltd. has announced that its board of directors will meet on August 22, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the recommendation for the payment of an interim dividend, highlighting the company’s ongoing financial activities and potential shareholder returns.
The most recent analyst rating on (HK:9996) stock is a Buy with a HK$4.00 price target. To see the full list of analyst forecasts on Peijia Medical Ltd. stock, see the HK:9996 Stock Forecast page.
More about Peijia Medical Ltd.
Peijia Medical Ltd. is a company incorporated in the Cayman Islands, operating in the medical industry. It focuses on developing and providing medical devices and solutions, with a market focus likely on healthcare and medical sectors.
Average Trading Volume: 2,213,165
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.68B
For a thorough assessment of 9996 stock, go to TipRanks’ Stock Analysis page.